Organigram Global (OGI) Depreciation & Amortization (CF) (2018 - 2026)
Organigram Global (OGI) posted quarterly Depreciation & Amortization (CF) of $7.3 million for Q1 2026, up 116.51% year-over-year from $3.4 million in Q1 2025, and up 104.46% quarter-over-quarter from $3.6 million in Q4 2025.
Organigram Global (OGI) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 116.51% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $14.2 million (up 145.73% YoY), while the FY2021 annual figure was $6.1 million, changed N/A from the prior year.
- Depreciation & Amortization (CF) grew to $7.3 million in Q1 2026 per OGI's latest filing, from $3.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $7.3 million in Q1 2026 and bottomed at $2.4 million in Q4 2024.
- Historically, Depreciation & Amortization (CF) has averaged $4.2 million across 3 years, with a median of $3.5 million in 2025.
- Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) soared 47.29% — and 2026, when it soared 116.51%.
- Organigram Global's Depreciation & Amortization (CF) stood at $2.4 million in 2024, then jumped by 47.29% to $3.6 million in 2025, then jumped by 104.46% to $7.3 million in 2026.
- Business Quant data shows OGI's Depreciation & Amortization (CF) at $7.3 million in Q1 2026, $3.6 million in Q4 2025, and $3.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn | 7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.30 Mn |
| Mar 31, 2026 | 7.30 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Dec 31, 2024 | 2.42 Mn |
| May 31, 2021 | 16.03 Mn |
| May 31, 2021 | 16.03 Mn |
| Feb 28, 2021 | 10.48 Mn |
| Feb 28, 2021 | 10.48 Mn |
| Nov 30, 2020 | 5.27 Mn |
| Nov 30, 2020 | 5.27 Mn |
| May 31, 2020 | 3.57 Mn |
| May 31, 2020 | 3.57 Mn |
| Feb 29, 2020 | 4.32 Mn |
| Feb 29, 2020 | 4.32 Mn |
| May 31, 2019 | 1.64 Mn |
| May 31, 2019 | 1.64 Mn |